Association of strong virus-specific CD4 T cell responses with efficient natural control of primary HIV-1 infection
暂无分享,去创建一个
D. Cornforth | I. Williams | J. Lifson | S. Gloster | P. Newton | G. Shaw | P. Borrow | Simone E. Gloster
[1] T. Waldmann,et al. Qualitative analysis of immune function in patients with the acquired immunodeficiency syndrome. Evidence for a selective defect in soluble antigen recognition. , 1985, The New England journal of medicine.
[2] S. J. Clark,et al. High titers of cytopathic virus in plasma of patients with symptomatic primary HIV-1 infection. , 1991, The New England journal of medicine.
[3] S. J. Clark,et al. High levels of HIV-1 in plasma during all stages of infection determined by competitive PCR. , 1993, Science.
[4] A. Fauci,et al. Kinetics of human immunodeficiency virus type 1 (HIV-1) DNA and RNA synthesis during primary HIV-1 infection. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[5] R. Zinkernagel,et al. Enhanced establishment of a virus carrier state in adult CD4+ T-cell-deficient mice , 1994, Journal of virology.
[6] R. Ahmed,et al. CD4+ T cells are required to sustain CD8+ cytotoxic T-cell responses during chronic viral infection , 1994, Journal of virology.
[7] S. Riddell,et al. Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor. , 1995, The New England journal of medicine.
[8] J. Weber,et al. An early antigen‐presenting cell defect in HIV‐1‐infected patients correlates with CD4 dependency in human T‐cell clones , 1996, Immunology.
[9] John W. Mellors,et al. Prognosis in HIV-1 Infection Predicted by the Quantity of Virus in Plasma , 1996, Science.
[10] M. Daucher,et al. The qualitative nature of the primary immune response to HIV infection is a prognosticator of disease progression independent of the initial level of plasma viremia. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[11] S. Patterson,et al. Bone marrow-derived dendritic cells, infection with human immunodeficiency virus, and immunopathology. , 1997, Annual review of immunology.
[12] E. Rosenberg,et al. Vigorous HIV-1-specific CD4+ T cell responses associated with control of viremia. , 1997, Science.
[13] M. Houghton,et al. Recurrence of hepatitis C virus after loss of virus specific CD4+ T cell response in acute hepatitis C , 1998 .
[14] J. Altman,et al. Viral Immune Evasion Due to Persistence of Activated T Cells Without Effector Function , 1998, The Journal of experimental medicine.
[15] Q. Sattentau,et al. Inactivation of Human Immunodeficiency Virus Type 1 Infectivity with Preservation of Conformational and Functional Integrity of Virion Surface Proteins , 1998, Journal of Virology.
[16] R. Zinkernagel,et al. Comparison of activation versus induction of unresponsiveness of virus-specific CD4+ and CD8+ T cells upon acute versus persistent viral infection. , 1998, Immunity.
[17] C. Pitcher,et al. HIV-1-specific CD4+ T cells are detectable in most individuals with active HIV-1 infection, but decline with prolonged viral suppression , 1999, Nature Medicine.
[18] T. Santantonio,et al. Recurrence of hepatitis C virus after loss of virus-specific CD4(+) T-cell response in acute hepatitis C. , 1999, Gastroenterology.
[19] M. McElrath,et al. Early and persistent human immunodeficiency virus type 1 (HIV-1)-specific T helper dysfunction in blood and lymph nodes following acute HIV-1 infection. , 1999, The Journal of infectious diseases.
[20] Y. Cao,et al. Pronounced acute immunosuppression in vivo mediated by HIV Tat challenge. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[21] E. Rosenberg,et al. Association between Virus-Specific Cytotoxic T-Lymphocyte and Helper Responses in Human Immunodeficiency Virus Type 1 Infection , 1999, Journal of Virology.
[22] P. Doherty,et al. Requirement for CD40 Ligand, CD4+ T Cells, and B Cells in an Infectious Mononucleosis-Like Syndrome , 1999, Journal of Virology.
[23] P. Easterbrook,et al. Early highly active antiretroviral therapy for acute HIV-1 infection preserves immune function of CD8+ and CD4+ T lymphocytes. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[24] E. Rosenberg,et al. Immune control of HIV-1 after early treatment of acute infection , 2000, Nature.
[25] K. Mansfield,et al. Identifying the Target Cell in Primary Simian Immunodeficiency Virus (SIV) Infection: Highly Activated Memory CD4+ T Cells Are Rapidly Eliminated in Early SIV Infection In Vivo , 2000, Journal of Virology.
[26] M. Altfeld,et al. The role of CD4(+) T helper cells in the cytotoxic T lymphocyte response to HIV-1. , 2000, Current opinion in immunology.
[27] E. Rosenberg,et al. Multiple Effector Functions Mediated by Human Immunodeficiency Virus-Specific CD4+ T-Cell Clones , 2001, Journal of Virology.
[28] P. Easterbrook,et al. Variable fate of virus-specific CD4(+) T cells during primary HIV-1 infection. , 2001, European journal of immunology.
[29] P. Easterbrook,et al. Variable fate of virus‐specific CD4+ T cells during primary HIV‐1 infection , 2001 .
[30] E. Rosenberg,et al. Cellular Immune Responses and Viral Diversity in Individuals Treated during Acute and Early HIV-1 Infection , 2001, The Journal of experimental medicine.
[31] M. Emerman,et al. Dendritic Cell-Mediated Viral Transfer to T Cells Is Required for Human Immunodeficiency Virus Type 1 Persistence in the Face of Rapid Cell Turnover , 2002, Journal of Virology.
[32] Anthony D. Kelleher,et al. Characterization of CD4+ CTLs Ex Vivo1 , 2002, The Journal of Immunology.
[33] B. Gazzard,et al. Accumulation of DC-SIGN+CD40+ dendritic cells with reduced CD80 and CD86 expression in lymphoid tissue during acute HIV-1 infection , 2002, AIDS.
[34] A. Telenti,et al. Analysis of HIV-1- and CMV-specific memory CD4 T-cell responses during primary and chronic infection. , 2002, Blood.
[35] J. Abastado,et al. HIV-1 Nef-induced upregulation of DC-SIGN in dendritic cells promotes lymphocyte clustering and viral spread. , 2002, Immunity.
[36] R. Steinman,et al. Endogenously Expressed nef Uncouples Cytokine and Chemokine Production from Membrane Phenotypic Maturation in Dendritic Cells1 , 2002, The Journal of Immunology.
[37] Z. Grossman,et al. HIV preferentially infects HIV-specific CD4+ T cells , 2002, Nature.
[38] A. Sette,et al. Early Induction and Maintenance of Env-Specific T-Helper Cells following Human Immunodeficiency Virus Type 1 Infection , 2003, Journal of Virology.
[39] E. Rosenberg,et al. Cytotoxic HIV-1 p55gag-Specific CD4+ T Cells Produce HIV-Inhibitory Cytokines and Chemokines , 2002, Journal of Clinical Immunology.